readthroughSign in
CompanyAMRXNasdaq

Amneal Pharmaceuticals, LLC

Amneal Pharmaceuticals develops approximately 300 complex generic, specialty, and biosimilar medicines across neurology, endocrinology, and other therapeutic areas.

10-QNov 9Latest SEC filing
Nov 4Latest story

November 2026

October 2026

September 2026

August 2026

July 2026